Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Dilatation of the intestinal lymphatic system usually caused by an obstruction in the intestinal wall. It may be congenital or acquired and is characterized by diarrhea; hypoproteinemia; peripheral and/or abdominal edema; and protein-losing enteropathies.
Biomarker and diagnostic research for intestinal lymphangiectasia has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for intestinal lymphangiectasia.
63 publications have been identified in PubMed for intestinal lymphangiectasia. Research spans Case Report / Case Series (52%), Review / Meta-Analysis (21%), and Diagnostic / Biomarker (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 33 | 52% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 9:28 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
13 |
21% |
Testing and diagnosis research | 4 | 6% |
Laboratory research | 4 | 6% |
Disease patterns and progression | 4 | 6% |
Other research | 2 | 3% |
New treatment approaches | 2 | 3% |
Clinical study results | 1 | 2% |
Kakkar C (2026). [PMID: 39899083](https://pubmed.ncbi.nlm.nih.gov/39899083/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]
Dai C (2026). [PMID: 40737280](https://pubmed.ncbi.nlm.nih.gov/40737280/). *Rev Esp Enferm Dig*. [Case Report / Case Series]
Tu CH (2026). [PMID: 41825717](https://pubmed.ncbi.nlm.nih.gov/41825717/). *Gastroenterology*. [Case Report / Case Series]
Carrigan L (2026). [PMID: 42125525](https://pubmed.ncbi.nlm.nih.gov/42125525/). *Eur Heart J Case Rep*. [Case Report / Case Series]
Rubio-Perez J (2026). [PMID: 41933582](https://pubmed.ncbi.nlm.nih.gov/41933582/). *J Thorac Oncol*. [Gene Therapy / Novel Therapeutics]
Li Y (2026). [PMID: 41122770](https://pubmed.ncbi.nlm.nih.gov/41122770/). *Clin Endosc*. [Basic Science / Preclinical]
Mortensen JK (2026). [PMID: 41593674](https://pubmed.ncbi.nlm.nih.gov/41593674/). *Acta Vet Scand*. [Case Report / Case Series]
Romero-Salazar FL (2026). [PMID: 42081996](https://pubmed.ncbi.nlm.nih.gov/42081996/). *Gastroenterol Hepatol*. [Case Report / Case Series]
Roepke E (2026). [PMID: 40934979](https://pubmed.ncbi.nlm.nih.gov/40934979/). *Gastroenterology*. [Case Report / Case Series]
Jennings N (2026). [PMID: 42110125](https://pubmed.ncbi.nlm.nih.gov/42110125/). *JPGN Rep*. [Case Report / Case Series]
AI-curated news mentioning intestinal lymphangiectasia
Updated May 11, 2026
A case report highlights profound protein-losing enteropathy and gastrointestinal hemorrhage due to intestinal lymphangiectasia in a patient with DiGeorge syndrome. This study contributes to the understanding of gastrointestinal complications associated with this genetic disorder.